University of Glasgow awarded over $1.1m to tackle Crohns disease in children...
The University of Glasgow has received $1.1 million from The Leona M. and Harry B. Helmsley Charitable Trust to evaluate the effectiveness of a novel regular solid foodbased diet to improve clinical...
View ArticleEuropean Medicines Agency Validates Marketing Application for Filgotinib for...
Gilead Sciences Inc. NASDAQ GILD and Galapagos NV Euronext & NASDAQ GLPG today announced that the Marketing Authorization Application MAA for filgotinib an investigational oral selective JAK1...
View ArticleRho Associated Protein Kinase 1 Renal Carcinoma Antigen NY REN 35 or Rho...
Rho Associated Protein Kinase 1 Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1 Pipeline Review H1 2019SummaryRho...
View ArticlePredictImmune Appoints Tim Rea of BGF as NonExecutive Director
Experienced entrepreneur and investor appointed with immediate effectPredictImmune developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in...
View ArticleGlobal Interleukin Inhibitors Market 20192023 13 CAGR Projection over the...
The global Interleukin inhibitors market 20192023 is expected to post a CAGR of more than 13 during the period 20192023 according to the latest market research report by Technavio. Request a free...
View ArticleLandos Biopharma Announces First Patient Dosed in Global Phase 2 Clinical...
Global clinical trial underway in 11 countries including U.S. European and Eastern European sites to evaluate safety efficacy and tolerability of orally administered gutrestricted LANCL2 agonist BT11...
View ArticleAntiTNF Tx Tied to Lower Risk of Arterial Events in IBD
MedPage Today Protective effect was more pronounced in men with Crohn's disease
View ArticleHuman medicines European public assessment report EPAR Flixabi infliximab...
Human medicines European public assessment report EPAR Flixabi infliximab Spondylitis AnkylosingArthritis RheumatoidCrohn DiseaseColitis UlcerativeArthritis PsoriaticPsoriasis Date of authorisation...
View ArticleGastrointestinal Disorders Innovative Pipeline Offers Potential for First...
Gastrointestinal Disorders Innovative Pipeline Offers Potential for First Approved Therapies in NASH and Celiac DiseaseSummaryThe burden of disease associated with gastrointestinal disorders is...
View ArticleDrug resistance signature discovered in Crohn's disease
By mapping out more than 100000 immune cells in patients with Crohn's disease researchers have discovered a signature of cells that are involved in a type of the disease that does not respond to...
View ArticleTrivedi Global Inc. Announces Research by Dahryn Trivedi on the Promising...
Over 80 increase in mitochondrial mass as indicated in preclinical researchLAS VEGAS PRWEB August 29 2019 Dahryn Trivedi today released preclinical research results on the beneficial impact of biofield...
View ArticleIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review H1 2019SummaryIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
View ArticleQuick Take Small Bowel Healing Detected by Endoscopy in Patients With Crohns...
In patients with Crohns disease CD endoscopic evidence of healing after treatment is associated with favorable outcomes. Antitumor necrosis factor TNF agents have been shown to induce ileocolonic...
View ArticleCrohn's Disease Regional Enteritis Pipeline Review H1 2019 Published by...
Crohn's Disease Regional Enteritis Pipeline Review H1 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Crohn's Disease Regional Enteritis Pipeline Review...
View ArticleToll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2019 Published...
Toll Like Receptor 4 hToll or CD284 or TLR4 Pipeline Review H1 2019SummaryAccording to the recently published report 'Toll Like Receptor 4 Pipeline Review H1 2019'; Toll Like Receptor 4 hToll or CD284...
View ArticleIBD research smashes recruitment target two years early
In the UK at least 300000 people are affected by Crohn’s disease or ulcerative colitis.
View ArticleEuropean Commission Approves Expanded Use of Janssens STELARAÂ ustekinumab...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission EC has approved the expanded use of ustekinumab for the treatment of adults with...
View ArticleSunMed CBD Wins Excellence Awards at CBD Expo
Fast growing product wholesaler wins Best CBD Tincture and Best CBD Topical at major showSunMed CBD has proudly announced that their company was awarded with two prestigious Excellence Awards at the...
View ArticleLonza to Produce Biosimilar for Celltrion
Swiss fine chemicals producer Lonza has signed a contract manufacturing agreement with Koreabased biosimilars producer Celltrion to supply a drug substance for Remsima a biosimilar that is approved by...
View ArticleCurcumin Shown Ineffective in Preventing Postsurgical Recurrent Crohn Disease
Oral curcumin was not more effective than placebo as an addon to thiopurines in a randomized trial.
View Article